{"product_id":"therapeutic-advances-in-thrombosis-isbn-9781405196253","title":"Therapeutic Advances in Thrombosis","description":"\u003cp\u003eManaging patients with thrombotic vascular disease is complex and challenging:\u003c\/p\u003e \u003cul\u003e \u003cli\u003eIschemic vascular disease remains a complicated interplay of atherosclerosis and thrombosis—even with the evolution in our understanding of the pathobiology of thrombosis.\u003c\/li\u003e \u003cli\u003eThere has been tremendous growth in therapeutic options which are quickly finding their place in daily practice, including a remarkable expansion in the number of intravenous and oral antithrombotic agents and new antiplatelet agents\u003c\/li\u003e \u003c\/ul\u003e \u003cp\u003eNow more than ever, all cardiologists, hematologists, and specialists in vascular medicine, as well as other professionals, such as hospital pharmacists, who deal with prognosis and intervention in preventing thrombosis, need a resource that distills current knowledge of this important subject.\u003c\/p\u003e \u003cp\u003eWritten and edited by today’s leading international, \u003cb\u003e\u003ci\u003eTherapeutic Advances in Thrombosis, 2e\u003c\/i\u003e\u003c\/b\u003e provides physicians with the very latest in medical and surgical advances in antithrombotic therapies. With this comprehensively updated edition you get:\u003c\/p\u003e \u003cul\u003e \u003cli\u003eCoverage of virtually all aspects of venous and arterial thrombotic disease and the corresponding therapies\u003c\/li\u003e \u003cli\u003eStrategies to manage specific clinical conditions and how to tailor treatment to individual patient needs\u003c\/li\u003e \u003cli\u003eUpdated chapters covering thrombolysis in ST-elevated myocardial infarctions; thrombosis in patients with diabetes, pregnancy, and renal dysfunction\u003c\/li\u003e \u003cli\u003eSpecial emphasis on the pharmacology of novel anticoagulants and their practical use in venous thromboembolism and atrial fibrillation.\u003c\/li\u003e \u003c\/ul\u003e \u003cp\u003ePlus, all chapters fully explore clinical trial designs and outcomes for particular treatment therapies, as well as contain the relevant ACC\/AHA\/ESC guidelines, so you can confidently apply what you learn.\u003c\/p\u003e  \u003cp\u003eContributors, vii\u003c\/p\u003e \u003cp\u003eForeword, x\u003c\/p\u003e \u003cp\u003ePreface, xi\u003c\/p\u003e \u003cp\u003e1 Arterial thrombosis: a brief overview, 1\u003cbr\u003e \u003ci\u003eLina Badimon and Valentin Fuster\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e2 Aspirin, 12\u003cbr\u003e \u003ci\u003eCarlo Patrono\u003cbr\u003e \u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e3 Platelet ADP P2Y12 inhibitors: thienopyridines, 26\u003cbr\u003e \u003ci\u003eJoseph D. Foley III and David J. Moliterno\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e4 Platelet ADP P2Y12 inhibitors: nonthienopyridines, 47\u003cbr\u003e \u003ci\u003eJoseph D. Foley III and David J. Moliterno\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e5 Cilostazol and dipyridamole: more than weak inhibition of platelets, 62\u003cbr\u003e \u003ci\u003eWolfgang G. Eisert\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e6 Interrelationship of thrombin and platelets: the protease activated receptor-1, 71\u003cbr\u003e \u003ci\u003eMatthew E. Wiisanen and David J. Moliterno\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e7 Glycoprotein IIb\/IIIa inhibitors, 87\u003cbr\u003e \u003ci\u003eMarco Valgimigli and Elisa Cangiano\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e8 Unfractionated heparin and low molecular weight heparin in ischemic heart disease, 111\u003cbr\u003e \u003ci\u003eZafar Iqbal, Omar Hasan, and Marc Cohen\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e9 Pentasaccharide derivatives, 128\u003cbr\u003e \u003ci\u003eAntonio Gutierrez, Pierluigi Tricoci, and John H.P. Alexander\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e10 Intravenous direct thrombin inhibitors, 150\u003cbr\u003e \u003ci\u003eFemi Philip and A. Michael Lincoff\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e11 Vitamin K antagonists, 166\u003cbr\u003e \u003ci\u003eFreek W.A. Verheugt\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e12 Oral direct thrombin inhibitors and oral factor Xa inhibitors, 180\u003cbr\u003e \u003ci\u003eSteen Husted and Lars Wallentin\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e13 Thrombolytic therapy and concomitant antithrombotic therapies, 189\u003cbr\u003e \u003ci\u003ePeter R. Sinnaeve and Frans J. Van de Werf\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e14 Antithrombotic therapy in ST-segment elevation myocardial infarction, 205\u003cbr\u003e \u003ci\u003eKurt Huber, Raffaele De Caterina, and Steen Dalby Kristensen\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e15 Antithrombotic therapy in non–ST-segment elevation acute coronary syndromes, 213\u003cbr\u003e \u003ci\u003eGeorgios J. Vlachojannis, Vijayalakshmi Kunadian, Joseph M. Sweeny, and Roxana Mehran\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e16 Antithrombotic strategies in patients undergoing elective percutaneous coronary intervention, 236\u003cbr\u003e \u003ci\u003eSunil V. Rao and E. Magnus Ohman\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e17 Antithrombotic management in patients with prosthetic valves, 246\u003cbr\u003e \u003ci\u003eEric G. Butchart and Raffaele De Caterina\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e18 Stroke: thrombolysis and antithrombotic therapy, 272\u003cbr\u003e \u003ci\u003eL. Creed Pettigrew and Michael R. Dobbs\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e19 Atrial fibrillation: current and forthcoming antithrombotic therapies, 285\u003cbr\u003e \u003ci\u003eRaffaele De Caterina and Giulia Renda\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e20 Venous thromboembolism: pathophysiology, diagnosis, and prophylaxis, 306\u003cbr\u003e \u003ci\u003eMarco P. Donadini, Walter Ageno, and Alexander G. Turpie\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e21 Antithrombotic therapy in venous thrombosis and pulmonary embolism, 317\u003cbr\u003e \u003ci\u003eMarcello Di Nisio and Harry R. Büller\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e22 Prevention and treatment of venous and arterial thrombosis in patients with specific conditions: diabetes, hypercoagulable states, pregnancy, and renal insufficiency, 327\u003cbr\u003e \u003ci\u003eMeyer Michel Samama, Jacqueline Conard, and Grigoris Gerotziafas\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e23 Genetics of the response to antithrombotic drugs and the need for monitoring, 357\u003cbr\u003e \u003ci\u003eJean-Philippe Collet, Gilles Montalescot, and Jean-Sébastien Hulot\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eIndex, 378\u003c\/p\u003e  \u003cp\u003e\u003cstrong\u003eDavid Moliterno\u003c\/strong\u003e, M.D, co-director of the Gill Heart Institute, professor of Internal Medicine and division chief of Cardiovascular Medicine at the University of Lexington, Kentucky. He is also inaugurated as the American College of Cardiology Governor of the Kentucky chapter for the years 2007-2010.\u003cbr\u003eHe has 189 articles published as listed on PubMed and is the author of the following books: \u003cem\u003eTherapeutic Strategies in Thrombosis 1E\u003c\/em\u003e; \u003cem\u003e900 Questions: An Interventional Cardiology Board Review\u003c\/em\u003e. \u003c\/p\u003e\u003cp\u003e\u003cstrong\u003eRaffaele De Caterina\u003c\/strong\u003e, MD, Institute of Cardiology, \"G. d'Annunzio\" University, Chieti, Italy.\u003cbr\u003eHe has 261 articles published as listed on PubMed and is the author of the following books: \u003cem\u003eTherapeutic Strategies in Thrombosis 1E\u003c\/em\u003e; \u003cem\u003eEndothelial Dysfunctions and Vascular Disease\u003c\/em\u003e. \u003c\/p\u003e\u003cp\u003e\u003cstrong\u003eSteen Dalby Kristensen\u003c\/strong\u003e, Department of Cardiology, Aarhus University Hospital, Aarhus N, Denmark.\u003cbr\u003eHe has 91 articles published as listed on PubMed and is the author of the following books: \u003cem\u003eTherapeutic Strategies in Thrombosis 1E\u003c\/em\u003e.\u003c\/p\u003e","brand":"Wiley-Blackwell","offers":[{"title":"Default Title","offer_id":47990381641957,"sku":"NP9781405196253","price":183.0,"currency_code":"USD","in_stock":false}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1842\/7735\/files\/9781405196253.jpg?v=1761787598","url":"https:\/\/k12savings.com\/es\/products\/therapeutic-advances-in-thrombosis-isbn-9781405196253","provider":"K12savings","version":"1.0","type":"link"}